Salim Mujais, MD, is a seasoned professional in the field of clinical development and medical affairs, currently serving as Senior Vice President of Clinical Development at Generate:Biomedicines. Previously, Mujais held the position of Senior Vice President and Head of Clinical Research Biopharma at Sumitomo Pharma America, Inc., and Senior Vice President, Head of Clinical Development at Urovant Sciences, Inc. Prior experience also includes multiple senior roles at Astellas Pharma, where responsibilities ranged from Senior Vice President and Therapeutic Area Head to Vice President of Medical Sciences. Mujais also served as Vice President of Medical Affairs and Medical Director in various capacities at Baxter. Educational credentials include studies at the University of Chicago and the Cleveland Clinic Lerner College of Medicine.
May, 2024 - present